نتایج جستجو برای: diphtheria toxoid

تعداد نتایج: 8415  

Journal: :MMWR. Morbidity and mortality weekly report 2009

On December 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) Boostrix (GlaxoSmithKline Biologicals, Rixensart, Belgium). Boostrix is now licensed for use in persons aged 10-64 years as a single-dose booster immunization; the vaccine initially was licensed for persons aged ...

2013
Aleksandra A Zasada Waldemar Rastawicki Natalia Rokosz Marek Jagielski Sheryl Ramos Aleksandra Zasada

Journal: :Journal of clinical microbiology 2012
E Farfour E Badell A Zasada H Hotzel H Tomaso S Guillot N Guiso

Corynebacterium diphtheriae, the agent of diphtheria, is rarely responsible for bacteremia. However, high numbers of bacteremia have been reported in countries with extensive immunization coverage. Here, we used molecular and phenotypic tools to characterize and compare 42 invasive isolates collected in France (including New Caledonia) and Poland over a 23-year period.

Journal: :Vaccine 2000
M Tiru H O Hallander L Gustafsson J Storsaeter P Olin

Data from two Swedish pertussis vaccine trials with various combination vaccines were used to compare anti-diphtheria antitoxin concentrations over time between different vaccines, vaccine lots and vaccine schedules. The immune responses were measured with a validated ELISA method.Results are given for 1326 children, born 1992, that were recruited to the placebo (DT)-controlled Trial I which us...

Journal: :MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 2008
Trudy V Murphy Barbara A Slade Karen R Broder Katrina Kretsinger Tejpratap Tiwari Patricia M Joyce John K Iskander Kristin Brown John S Moran

In 2005, two tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines were licensed and recommended for use in adults and adolescents in the United States: ADACEL (sanofi pasteur, Swiftwater, Pennsylvania), which is licensed for use in persons aged 11--64 years, and BOOSTRIX (GlaxoSmithKline Biologicals, Rixensart, Belgium), which is licensed for use in persons aged 10...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997
M E Pichichero S Passador

We compared antibody levels following separate but simultaneous administration of diphtheria and tetanus toxoids with acellular pertussis vaccine (DTaP) containing pertussis toxoid, filamentous hemagglutinin, and pertactin (PRN); hepatitis B vaccine; and Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate; PRP) vaccine conjugated to tetanus toxoid (PRP-T) with those follo...

2017
Mignon du Plessis Nicole Wolter Mushal Allam Linda de Gouveia Fahima Moosa Genevie Ntshoe Lucille Blumberg Cheryl Cohen Marshagne Smith Portia Mutevedzi Juno Thomas Valentino Horne Prashini Moodley Moherndran Archary Yesholata Mahabeer Saajida Mahomed Warren Kuhn Koleka Mlisana Kerrigan McCarthy Anne von Gottberg

In 2015, a cluster of respiratory diphtheria cases was reported from KwaZulu-Natal Province in South Africa. By using whole-genome analysis, we characterized 21 Corynebacterium diphtheriae isolates collected from 20 patients and contacts during the outbreak (1 patient was infected with 2 variants of C. diphtheriae). In addition, we included 1 cutaneous isolate, 2 endocarditis isolates, and 2 ar...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید